Form D · Pharmaceuticals
Valeo Pharma Inc.
Kirkland, A8 · CIK 0001904395
Offering snapshot reported Jan 13, 2022 · SEC filing
- Reported sold
- $787K Offering amount: $787K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 9, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 13, 2022 | Initial | $787,400 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $55.1K (estimated)
- Form D file number
- 021-429329
Total Offering Amount represents aggregate principal amount of C$1,000,000 convertible debenture. There is no guarantee that the convertible debenture will be converted into common shares of the Issuer. Exchange rate C$1: US$0.7874.
12% convertible unsecured subordinated debenture, maturing on December 31, 2024, convertible into common shares.
Finder's Fees represents cash fee of C$70,000, converted to US$, were paid to Desjardins Securities International Inc.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Desjardins Securities International Inc. | 112417 |
Source: Form D, filed Jan 13, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Guy Paul Allard | Executive |
| Maureen C. Breenan | Director |
| Michelle Brien | Executive |
| Frederic Fasano | Director, Executive |
| Vincent P. Hogue | Director |
| Nelly Komari | Executive |
| Richard J. Mackay | Director, Executive |
| Luc Mainville | Executive |
| Steve Saviuk | Director, Executive |
| Helen Saviuk | Executive |
| Jeff Skinner | Executive |
| Nathalie Therrien | Executive |
| Michel Trudeau | Director |
| Michael G. Wells | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
16667, Hymus Blvd.
Kirkland, A8, H9H 4R9
Kirkland, A8, H9H 4R9